HEALTH-RELATED QUALITY OF LIFE IN CHRONIC LIVER DISEASE: CLINICAL BURDEN, DETERMINANTS, AND IMPLICATIONS FOR PATIENT-CENTERED CARE. [PDF]
Dezan MGF +5 more
europepmc +1 more source
The Impact of Type 2 Diabetes Mellitus on Hepatic Fibrosis in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: A Cross-Sectional Study. [PDF]
Mesquita P +5 more
europepmc +1 more source
THE IL-6/IL-10 INFLAMMATORY AXIS AND PROGNOSIS OF CIRRHOSIS-ASSOCIATED HEPATOCELLULAR CARCINOMA: A NARRATIVE REVIEW. [PDF]
Rezende RB.
europepmc +1 more source
Unveiling the Link between MASLD-Associated Liver Fibrosis and Subclinical Atherosclerosis. [PDF]
Izar MC, Fonseca FAH.
europepmc +1 more source
ROLE OF STATINS IN CIRRHOTIC PORTAL HYPERTENSION: META-ANALYSIS OF RANDOMIZED STUDIES. [PDF]
Moreno MOA +6 more
europepmc +1 more source
Paraneoplastic Pemphigus and Liver Biopsy Needle Track Dissemination in Hepatocellular Carcinoma: A Case Report. [PDF]
Palma C +5 more
europepmc +1 more source
Ultrasound-based liver elastography: a narrative review of technical principles and interpretation of results. [PDF]
Souza FF +3 more
europepmc +1 more source
[Clinical and Imaging Features in Patients with Cirrhosis and Hepatocellular Carcinoma at a Tertiary Hospital in Córdoba] [PDF]
Oliva V, Muiño G, Orozco S, Saad EJ.
europepmc +1 more source
Relationship between Liver Fibrosis Due to Metabolic Dysfunction-Associated Steatotic Liver Disease and Subclinical Atherosclerosis. [PDF]
Coutinho DAA +10 more
europepmc +1 more source
Beyond Biopsy: Real-World Evaluation of the Fibrosis-6 Score in a Portuguese Cohort. [PDF]
Simas D +8 more
europepmc +1 more source

